https://parkinsonsnewstoday.com/news/vaccine-targeting-alpha-synuclein-moves-closer-human-trials/
0
0
New Vaccine for Parkinson's Moves Closer to 1st Human Trials | Vaccine Spurs Immune Response in 3 Regions of Alpha-synuclein - Parkinson's News Today
+ 81 more
12/1/22 at 1:04pm
Organization
Parkinson's News Today
Authors
Marisa Wexler MS
45 words
0
Comments
An experimental vaccine that targets alpha-synuclein — whose toxic clumps drive Parkinson's — is moving into late-stage preclinical research.
2 similar articles
HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward' - CNN
Early-Stage HIV Vaccine Shows Positive Results In Human Trials: Study - NDTV
You are the first to view
Create an account or login to join the discussion